Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 5, 2024 (GLOBE NEWSWIRE) — According to the report published by Market research on transparencythe world cup Particle therapy market (Particle therapy market) was worth US$ 603.5 Mn in 2022 and is expected to reach US$ 1.3 billion by 2031 at a CAGR of 8.6 % between 2023 and 2031.
Particle therapy, also known as particle beam therapy, is an advanced form of radiation therapy used to treat cancer by precisely targeting and destroying malignant cells. This technique uses charged particles, such as protons or heavier ions, such as carbon, to deliver highly concentrated doses of radiation. The increasing incidence and prevalence of cancer worldwide is driving demand for more sophisticated treatment options, including particle therapy.
As cancer cases continue to rise, there is a growing need for effective targeted therapies such as particle therapy. This cutting-edge treatment offers a novel approach to cancer treatment by using external beams of protons and neutrons to target tumors. When these energetic ionizing particles are discharged at the tumor site, they break up the DNA within the cancer cells, ultimately leading to tumor destruction.
Particle therapy market outlook
Particle therapy is an innovative type of cancer treatment that uses charged particles, such as protons and heavy ions, to precisely target tumors. This method applies energy directly to cancerous tissues without affecting surrounding healthy cells, thereby reducing side effects and improving treatment effectiveness.
For more details, request a sample of this research report:
Thanks to its modulated energy deposition and superior dose distribution, particle therapy is particularly effective in treating complex tumors, pediatric cases, and cancers resistant to conventional radiation. Although high costs and the specialized facilities required have limited its widespread adoption, particle therapy has the potential to revolutionize cancer care by significantly improving patient outcomes and quality of life during and after treatment.
Advances in cancer treatments and the increasing frequency of difficult-to-treat cancers are driving strong growth in the particle therapy market. By reducing exposure to healthy tissue, highly charged particle therapy, such as protons and carbon ions, is especially effective for tumors close to vital organs, such as the spinal cord and bones.
Carbon ion therapy is a potential alternative method for treating tumors because it delivers higher doses of radiation compared to proton therapy, which is the most commonly used type of particle therapy.
The current number of carbon ion therapy facilities in operation worldwide stands at just 13, but six more are under construction, suggesting increased focus and investment in this treatment system. Furthermore, the European strategy to increase the number of particle therapy hospitals to 45 by next year indicates an expansion of capabilities that will help meet patient demand and therefore an increase in sales is expected.
The particle therapy market, which has the potential to revolutionize cancer treatment, has yet to deliver on its promise due to challenges such as the high cost of equipment and infrastructure required for particle acceleration. As a result, many healthcare providers are unable to access particle therapies. Furthermore, the complexity of these systems requires ongoing training and specialized skills, so they may not be easily adopted in practice settings.
Given their pivotal role in the decision-making process regarding therapeutic options for cancer patients, it is anticipated that more healthcare professionals will be aware of the benefits of screening using charged particles rather than conventional photons by 2025 or beyond, when insurance coverage (due to their unpopularity) will be less likely to be offered for such procedures that are in greater public demand, even if timing is not always heeded.
Overall, although challenges continue to persist, particle beam therapy is projected to experience considerable growth, driven primarily by creativity coupled with increasing demand for greater precision in cancer treatment.
Scope of Particle Therapy Market Report:
| Report coverage | Details |
| Forecast period | 2023-2031 |
| Base year | 2017-2021 |
| Size in 2022 | US$ 603.5 million |
| Forecast (value) in 2031 | US$ 1.3 billion |
| Compound Annual Growth Rate (CAGR) | 8.6% |
| Number of pages | 189 pages |
| Segments covered | By therapy, by services, by application, end user, by region. |
Regional outlook for particle therapy market
• North America generated the largest market value in 2023. The region is also expected to maintain its dominance during the forecast period.
The particle therapy market in North America is experiencing significant growth, driven by several key factors. One of the major contributors is the rising prevalence of cancer across the region. With increasing cancer incidence rates, there is a growing demand for advanced treatment modalities that offer precise targeting of tumors and minimize damage to surrounding healthy tissues.
Particle therapy, with its ability to deliver highly concentrated doses of radiation, is gaining ground as an effective treatment option, particularly for complex and difficult-to-treat cancers. This has led to increased investment in particle therapy centers and equipment across North America.
Key developments
Advanced Oncotherapy PLC, Danfysik A/S, Hitachi, Ltd., IBA Worldwide, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, and Varian Medical Systems, Inc. are some of the major key players operating in the global industry.
For full report details, request a sample copy here:
Recent events
January 2024: The National Association for Proton Therapy (NAPT), the leading organization committed to improving patient access to advanced cancer treatments, has updated the International Journal of Radiation Oncology, Biology and Physics with the results of a study that delves deeper into the use of proton therapy for an expanding range of medical conditions and tumor sites.
Market segmentation
Therapy
- Proton therapy
- Heavy metal (Carbon therapy, He, Pion, etc.)
- Services
- Cyclotrons
- Synchrotrons
- Synchrocyclotrons
Application
- Pediatric cancer
- Lung cancer
- Bladder cancer
- Brain and spinal cord tumors (BSCT)
- Breast cancer
- Gastrointestinal (GI) cancers
- Hepatocellular carcinoma (HCC)
- Head and neck cancers (HNC)
- Others
End user
- Hospitals
- Academic and research centers
More trend reports from Transparency Market Research:
About Transparency Market Research
Market research on transparencya world cup market research company Registered in Wilmington, Delaware, USA, we offer customized research and consulting services. Our unique combination of quantitative forecasting and trend analysis provides forward-looking insights for thousands of decision makers. Our experienced team of analysts, researchers and consultants utilize proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and reviewed by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTERS IN THE CITY CENTER,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801, USA
Phone: +1-518-618-1030
USA – Canada Toll Free Line:866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow us: LinkedIn| Twitter| Blog | YouTube
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.